Trial Profile
A Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of ASP8477 in Healthy Postmenopausal Females and Healthy Young Vasectomized Males, Including a Food Effect Part and a Part to Investigate the Interaction Between ASP8477 and Omeprazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 8477 (Primary) ; Omeprazole
- Indications Neuropathic pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 23 Aug 2014 New trial record